Cargando…
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
α-synuclein (aSyn) is associated with both sporadic and familial forms of Parkinson’s disease (PD), the second most common neurodegenerative disorder after Alzheimer’s disease. In particular, multiplications and point mutations in the gene encoding for aSyn cause familial forms of PD. Moreover, the...
Autores principales: | Lázaro, Diana F., Dias, Mariana Castro, Carija, Anita, Navarro, Susanna, Madaleno, Carolina Silva, Tenreiro, Sandra, Ventura, Salvador, Outeiro, Tiago F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148884/ https://www.ncbi.nlm.nih.gov/pubmed/27938414 http://dx.doi.org/10.1186/s40478-016-0402-8 |
Ejemplares similares
-
Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity
por: Carija, Anita, et al.
Publicado: (2019) -
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
por: Lázaro, Diana F., et al.
Publicado: (2014) -
Antibodies against Alpha-Synuclein Reduce Oligomerization in Living Cells
por: Näsström, Thomas, et al.
Publicado: (2011) -
Data on correlation between Aβ42 structural aggregation propensity and toxicity in bacteria
por: Carija, Anita, et al.
Publicado: (2016) -
Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)